Bicarbonate

Bicarbonate

SCHEMBL4944902

CCCCN1CCC(NCCCN2c3ccccc3N(c3ccccc3F)S2(O)O)CC1.O=C(O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.44
SLC6A3 Q01959 1/20 0.44
CYP2D6 P10635 3/20 0.41
CYP1A2 P05177 2/20 0.41
SLC6A4 P31645 1/20 0.41
HTR6 P50406 2/20 0.41
UBE2M P61081 4/20 0.40
DCUN1D1 Q96GG9 4/20 0.40
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
CHRM1 P11229 2/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL4944891 0.91 SLC6A2 (0.56) SLC6A2SLC6A3CYP2D6CYP1A2SLC6A4
Bicarbonate SCHEMBL3611784 0.90 SLC6A2 (0.41) SLC6A2SLC6A3SLC6A4HTR6UBE2M
SCHEMBL4060785 0.84 SLC6A2 (0.50) SLC6A2SLC6A3SLC6A4
SCHEMBL4944896 0.83 SLC6A2 (0.40) SLC6A2SLC6A3CYP2D6CYP1A2SLC6A4
SCHEMBL3611833 0.83 CHRM1 (0.47) SLC6A2SLC6A3CHRM1ALDH1A1KCNH2
Bicarbonate SCHEMBL3611777 0.82 SLC6A2 (0.52) SLC6A2SLC6A3SLC6A4HTR6KCNH2
SCHEMBL4056089 0.81 SLC6A2 (0.51) SLC6A2SLC6A3SLC6A4
SCHEMBL4062392 0.80 SLC6A2 (0.46) SLC6A2SLC6A3SLC6A4
Hydrochloric Acid SCHEMBL4947134 0.79 SLC6A2 (0.45) SLC6A2SLC6A3SLC6A4
SCHEMBL3612639 0.77 SLC6A2 (0.42) SLC6A2SLC6A3SLC6A4CHRM1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161366-A1 AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161366-A1 AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE SLC6A4, SLC6A2, SLC6A3 SLC6A2 2/4885SLC6A3 3/4885CYP2D6 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.